Working… Menu
Trial record 1 of 1 for:    Cantrixil
Previous Study | Return to List | Next Study

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02903771
Recruitment Status : Completed
First Posted : September 16, 2016
Last Update Posted : April 20, 2020
Information provided by (Responsible Party):
Kazia Therapeutics Limited

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 24, 2020
Actual Study Completion Date : March 24, 2020